GW Pharma Wants Judge To Nix Investor Suit Over $7.2B Deal
GW Pharmaceuticals has asked a California federal judge to toss a proposed securities class action alleging the company misled investors to achieve a $7.2 billion acquisition deal, arguing that the purportedly...To view the full article, register now.
Already a subscriber? Click here to view full article